Arkolith/Insider Trading/DNTH/Form 4

Randhawa Simrat

EVP, Head of R&DDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
11
7 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)4K$8.44$34K8K
Jun 1, 2026Option exercise(M)7K$17.88$124K15K
Jun 1, 2026Option exercise(M)6K$21.77$136K21K
Jun 1, 2026Option exercise(M)9K$22.07$207K31K
Jun 1, 2026Sell(S)5K$89.72$487K25K
Jun 1, 2026Sell(S)17K$90.72$1.5M8K
Jun 1, 2026Sell(S)4K$91.37$380K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 1, 2026Option exercise(M)4K—$00
Jun 1, 2026Option exercise(M)7K—$064K
Jun 1, 2026Option exercise(M)6K—$048K
Jun 1, 2026Option exercise(M)9K—$097K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001992260-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML